Table 4.
CFU and MP-FCM results correlation and non-correlation.
| Antimicrobial treatment | Target microorganisms | MP-FCM Dyes | Reference | |
|---|---|---|---|---|
| CFU and FCM results correlation | Carvacrol + nisin combined with irradiation | Bacillus cereus (vegetative cells) | PI/cFDA | Ayari et al., 2013 |
| Pulsed magnetic fields | Staphylococcus spp., Escherichia coli | Syto9/PI | Boda et al., 2015 | |
| TiO2-nanoparticles | Pseudomonas putida | SYBR-I, PI/cFDA | Combarros et al., 2016 | |
| Lipopeptide antibiotics derived from polymyxin B | Staphylococcus aureus, E. coli | PI/DiBAC4 | Grau-Campistany et al., 2016 | |
| Essential oils | Lactic acid bacteria | PI/cFDA | Hayouni et al., 2008 | |
| Essential oils | Listeria monocytogenes | Syto9/PI | Muñoz et al., 2009 | |
| D-erythro-sphingosine | Escherichia coli | Syto9/PI | Possemiers et al., 2005 | |
| UV-A photocalalysis | Saccharomyces cerevisiae | PI/cFDA-AM | Thabet et al., 2013 | |
| CFU and FCM results non-correlation | High hydrostatic pressure | Lactobacillus rhamnosus GG | PI/cFDA | Ananta et al., 2004 |
| Carvacrol or nisin | Bacillus cereus (vegetative cells) | PI/cFDA | Ayari et al., 2013 | |
| Resveratrol inclusion complexes | Campylobacter spp., Arcobacter butzleri | Syto40/DiBAC4 | Duarte et al., 2015 | |
| Super-critical CO2 | Listeria monocytogenes | SYBR-I/PI | Ferrentino et al., 2015 | |
| Super-critical CO2 | Salmonella enterica | Syto9/EB | Kim et al., 2009 | |
| Pulsed light | Listeria innocua, E. coli | PI, DiBAC4, EB, cFDA | Kramer and Muranyi, 2014 | |
| Thermal treatment | L. innocua, E. coli, S. aureus, S. enterica | PI, DiBAC4, EB, cFDA | Kramer and Thielmann, 2016 | |
| Super-critical CO2 | S. aureus, E. coli | Syto9/PI | Li H. et al., 2015 | |
| Blue light-activated curcumin | Streptococcus mutans | Syto9/PI | Manoil et al., 2014 | |
| Silver | L. monocytogenes, S. enterica | Syto9/PI | Martínez-Abad et al., 2012 | |
| Ultra-high hydrostatic pressure and mild heat | Bacillus subtilis (vegetative cells) | PI/cFDA | Meng et al., 2016 | |
| NaCl | Aeromonas hydrophila | SYBR-I/PI | Pianetti et al., 2008 | |
| UV-C light | L. innocua, E. coli, S. cerevisiae | PI/cFDA | Schenk et al., 2011 | |
| Super-critical CO2 | S. cerevisiae | SYBR-I/PI | Spilimbergo et al., 2010 | |
| Super-critical CO2 | L. monocytogenes, S. enterica, E. coli | SYBR-I/PI | Tamburini et al., 2013 |
PI, Propidium Iodide; cFDA, carboxyFluorescein DiAcetate; cFDA-AM, carboxyFluorescein DiAcetate-acetoxymethyl; DiBAC4, Bis-(1,3-DibutylBarbituric ACid) Trimethine Oxonol = bis-oxonol = BOX; EB, Ethidium Bromide.